Cargando…
P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430679/ http://dx.doi.org/10.1097/01.HS9.0000846980.34790.f7 |
| _version_ | 1784779840906330112 |
|---|---|
| author | Kuykendall, A. Kremyanskaya, M. Ginsburg, Y. Pemmaraju, N. Ritchie, E. Gotlib, J. Valone, F. Khanna, S. Gupta, S. Hoffman, R. Verstovsek, S. |
| author_facet | Kuykendall, A. Kremyanskaya, M. Ginsburg, Y. Pemmaraju, N. Ritchie, E. Gotlib, J. Valone, F. Khanna, S. Gupta, S. Hoffman, R. Verstovsek, S. |
| author_sort | Kuykendall, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430679 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306792022-08-31 P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA Kuykendall, A. Kremyanskaya, M. Ginsburg, Y. Pemmaraju, N. Ritchie, E. Gotlib, J. Valone, F. Khanna, S. Gupta, S. Hoffman, R. Verstovsek, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430679/ http://dx.doi.org/10.1097/01.HS9.0000846980.34790.f7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kuykendall, A. Kremyanskaya, M. Ginsburg, Y. Pemmaraju, N. Ritchie, E. Gotlib, J. Valone, F. Khanna, S. Gupta, S. Hoffman, R. Verstovsek, S. P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA |
| title | P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA |
| title_full | P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA |
| title_fullStr | P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA |
| title_full_unstemmed | P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA |
| title_short | P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA |
| title_sort | p1028: ptg-300 (rusfertide) treatment interruption reverses hematological gains and restores therapeutic benefit on reinitiation in subjects with polycythemia vera |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430679/ http://dx.doi.org/10.1097/01.HS9.0000846980.34790.f7 |
| work_keys_str_mv | AT kuykendalla p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT kremyanskayam p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT ginsburgy p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT pemmarajun p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT ritchiee p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT gotlibj p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT valonef p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT khannas p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT guptas p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT hoffmanr p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera AT verstovseks p1028ptg300rusfertidetreatmentinterruptionreverseshematologicalgainsandrestorestherapeuticbenefitonreinitiationinsubjectswithpolycythemiavera |